Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0353 Transporter Info | ||||
Gene Name | SLC40A1 | ||||
Transporter Name | Iron-regulated transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Prostate cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in prostate cancer | [ 1 ] | |||
Location |
5'UTR (cg16427983) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.47E-03; Z-score:4.08E+00 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 8.31E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg21515032) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:8.75E-03; Z-score:2.78E+00 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 8.65E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in prostate cancer | [ 1 ] | |||
Location |
TSS1500 (cg09168997) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:1.97E-02; Z-score:1.86E+00 | ||
Methylation in Case |
7.70E-01 (Median) | Methylation in Control | 6.72E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg04361126) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.75E+00 | Statistic Test | p-value:9.97E-09; Z-score:-9.02E+00 | ||
Methylation in Case |
2.19E-01 (Median) | Methylation in Control | 6.03E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.71E+00 | Statistic Test | p-value:6.04E-06; Z-score:-5.34E+00 | ||
Methylation in Case |
1.66E-01 (Median) | Methylation in Control | 2.84E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg14126583) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:1.01E-02; Z-score:-1.37E+00 | ||
Methylation in Case |
6.34E-02 (Median) | Methylation in Control | 8.24E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:1.95E-02; Z-score:1.19E+00 | ||
Methylation in Case |
3.57E-02 (Median) | Methylation in Control | 3.01E-02 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg15599483) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:5.36E-07; Z-score:5.91E+00 | ||
Methylation in Case |
8.86E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg04361126) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.47E+00 | Statistic Test | p-value:4.75E-15; Z-score:-2.60E+00 | ||
Methylation in Case |
4.32E-01 (Median) | Methylation in Control | 6.35E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:2.72E-11; Z-score:-1.47E+00 | ||
Methylation in Case |
2.81E-01 (Median) | Methylation in Control | 3.34E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg11483915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:5.62E-04; Z-score:7.15E-01 | ||
Methylation in Case |
8.80E-02 (Median) | Methylation in Control | 7.46E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:7.35E-03; Z-score:3.76E-01 | ||
Methylation in Case |
5.83E-02 (Median) | Methylation in Control | 4.91E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg14126583) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.36E+00 | Statistic Test | p-value:1.11E-04; Z-score:-1.08E+00 | ||
Methylation in Case |
3.54E-02 (Median) | Methylation in Control | 4.81E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:3.67E-03; Z-score:1.72E+00 | ||
Methylation in Case |
4.39E-01 (Median) | Methylation in Control | 3.91E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg11483915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:3.84E-03; Z-score:6.25E-01 | ||
Methylation in Case |
3.21E-02 (Median) | Methylation in Control | 2.41E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:3.19E-02; Z-score:1.19E-01 | ||
Methylation in Case |
3.47E-02 (Median) | Methylation in Control | 3.41E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg09606941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:4.76E-02; Z-score:1.40E-01 | ||
Methylation in Case |
1.47E-02 (Median) | Methylation in Control | 1.19E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg24634422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.29E+00 | Statistic Test | p-value:5.98E-04; Z-score:5.31E+00 | ||
Methylation in Case |
1.85E-01 (Median) | Methylation in Control | 8.05E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
TSS1500 (cg15577178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.44E+00 | Statistic Test | p-value:6.20E-04; Z-score:5.21E+00 | ||
Methylation in Case |
2.99E-01 (Median) | Methylation in Control | 1.23E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg17065011) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:3.32E-05; Z-score:-3.37E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 5.74E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in colon adenocarcinoma | [ 5 ] | |||
Location |
Body (cg26877715) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.80E+00 | Statistic Test | p-value:4.57E-03; Z-score:1.96E+00 | ||
Methylation in Case |
1.18E-01 (Median) | Methylation in Control | 6.56E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg04361126) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.41E+00 | Statistic Test | p-value:2.80E-08; Z-score:-2.06E+00 | ||
Methylation in Case |
4.85E-01 (Median) | Methylation in Control | 6.85E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in colorectal cancer | [ 6 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:1.66E-02; Z-score:-8.09E-01 | ||
Methylation in Case |
3.37E-01 (Median) | Methylation in Control | 3.86E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg04625905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:3.10E-16; Z-score:-3.13E+00 | ||
Methylation in Case |
4.75E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg09606941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:8.27E-04; Z-score:-6.22E-01 | ||
Methylation in Case |
1.86E-02 (Median) | Methylation in Control | 2.82E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg11483915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:3.98E-03; Z-score:-6.22E-01 | ||
Methylation in Case |
6.85E-02 (Median) | Methylation in Control | 8.13E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS1500 (cg14126583) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:2.18E-02; Z-score:-4.10E-01 | ||
Methylation in Case |
8.13E-02 (Median) | Methylation in Control | 8.77E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg13394305) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:2.45E-02; Z-score:-2.65E-01 | ||
Methylation in Case |
2.01E-02 (Median) | Methylation in Control | 2.47E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg12142062) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.65E+00 | Statistic Test | p-value:3.97E-21; Z-score:-8.54E+00 | ||
Methylation in Case |
4.01E-01 (Median) | Methylation in Control | 6.64E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg22077670) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.56E+00 | Statistic Test | p-value:1.51E-14; Z-score:-2.61E+00 | ||
Methylation in Case |
4.29E-01 (Median) | Methylation in Control | 6.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg08792812) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.62E+00 | Statistic Test | p-value:1.90E-13; Z-score:-2.16E+00 | ||
Methylation in Case |
3.08E-01 (Median) | Methylation in Control | 4.98E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC40A1 in hepatocellular carcinoma | [ 7 ] | |||
Location |
3'UTR (cg16758084) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.37E+00 | Statistic Test | p-value:6.29E-15; Z-score:-7.00E+00 | ||
Methylation in Case |
6.30E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg09606941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.55E+00 | Statistic Test | p-value:3.97E-05; Z-score:2.43E+00 | ||
Methylation in Case |
4.91E-02 (Median) | Methylation in Control | 1.92E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg11483915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:4.96E-04; Z-score:1.50E+00 | ||
Methylation in Case |
9.38E-02 (Median) | Methylation in Control | 6.68E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg04361126) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.17E+00 | Statistic Test | p-value:1.91E-03; Z-score:1.16E+00 | ||
Methylation in Case |
3.21E-01 (Median) | Methylation in Control | 2.74E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.76E+00 | Statistic Test | p-value:5.82E-03; Z-score:1.00E+00 | ||
Methylation in Case |
2.74E-02 (Median) | Methylation in Control | 1.56E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:8.29E-03; Z-score:8.62E-01 | ||
Methylation in Case |
3.05E-01 (Median) | Methylation in Control | 2.73E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg15893070) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:1.65E-02; Z-score:5.50E-01 | ||
Methylation in Case |
2.30E-02 (Median) | Methylation in Control | 1.82E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC40A1 in HIV infection | [ 8 ] | |||
Location |
Body (cg15599483) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.83E-18; Z-score:1.92E+00 | ||
Methylation in Case |
9.08E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg11483915) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.75E+00 | Statistic Test | p-value:7.29E-03; Z-score:5.86E+00 | ||
Methylation in Case |
1.70E-01 (Median) | Methylation in Control | 9.73E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.45E+00 | Statistic Test | p-value:1.09E-02; Z-score:1.86E+00 | ||
Methylation in Case |
6.21E-02 (Median) | Methylation in Control | 4.30E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg09606941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.46E+00 | Statistic Test | p-value:1.72E-02; Z-score:3.31E+00 | ||
Methylation in Case |
1.17E-01 (Median) | Methylation in Control | 4.75E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg15893070) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:1.92E-03; Z-score:2.21E+00 | ||
Methylation in Case |
7.10E-02 (Median) | Methylation in Control | 5.19E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS200 (cg13394305) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.35E+00 | Statistic Test | p-value:1.24E-02; Z-score:1.13E+01 | ||
Methylation in Case |
1.10E-01 (Median) | Methylation in Control | 3.27E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in panic disorder | [ 10 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.85E-01 | Statistic Test | p-value:1.57E-02; Z-score:-3.35E-01 | ||
Methylation in Case |
-4.61E+00 (Median) | Methylation in Control | -4.55E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in panic disorder | [ 10 ] | |||
Location |
TSS1500 (cg09606941) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.84E-01 | Statistic Test | p-value:2.34E-02; Z-score:-1.17E-01 | ||
Methylation in Case |
-6.39E+00 (Median) | Methylation in Control | -6.29E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in panic disorder | [ 10 ] | |||
Location |
1stExon (cg10752008) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.50E-01 | Statistic Test | p-value:3.41E-02; Z-score:-4.40E-01 | ||
Methylation in Case |
-3.47E+00 (Median) | Methylation in Control | -3.30E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg14499385) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:5.08E-06; Z-score:1.38E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg04361126) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:5.82E-04; Z-score:1.08E+00 | ||
Methylation in Case |
7.15E-01 (Median) | Methylation in Control | 6.49E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC40A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg21660960) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.37E-02; Z-score:5.53E-01 | ||
Methylation in Case |
9.23E-02 (Median) | Methylation in Control | 8.61E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC40A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg14126583) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.15E-02; Z-score:-1.03E-01 | ||
Methylation in Case |
1.12E-01 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC40A1 in papillary thyroid cancer | [ 11 ] | |||
Location |
1stExon (cg10752008) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:3.83E-02; Z-score:4.61E-01 | ||
Methylation in Case |
8.99E-02 (Median) | Methylation in Control | 8.43E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS1500 (cg14126583) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.06E-02; Z-score:-4.56E-02 | ||
Methylation in Case |
1.01E-01 (Median) | Methylation in Control | 1.03E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS200 (cg13394305) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:9.91E-03; Z-score:-2.33E-02 | ||
Methylation in Case |
1.34E-02 (Median) | Methylation in Control | 1.41E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
1stExon (cg10752008) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.73E+00 | Statistic Test | p-value:2.01E-19; Z-score:2.98E+00 | ||
Methylation in Case |
6.22E-01 (Median) | Methylation in Control | 3.60E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in atypical teratoid rhabdoid tumor | [ 13 ] | |||
Location |
Body (cg01158447) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:4.87E-05; Z-score:-6.24E-01 | ||
Methylation in Case |
3.70E-01 (Median) | Methylation in Control | 4.46E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in depression | [ 14 ] | |||
Location |
Body (cg15599483) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:4.60E-02; Z-score:-5.41E-01 | ||
Methylation in Case |
6.73E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC40A1 in pancretic ductal adenocarcinoma | [ 15 ] | |||
Location |
Body (cg18781372) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.95E-05; Z-score:-2.89E-01 | ||
Methylation in Case |
8.45E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC40A1 in pancretic ductal adenocarcinoma | [ 15 ] | |||
Location |
Body (cg19717347) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.37E-03; Z-score:-6.39E-01 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Oligodendroglial tumour |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate hypermethylation of SLC40A1 in oligodendroglial tumour than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglial tumour [ICD-11:2A00.Y1] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.27E-09; Fold-change:0.264081071; Z-score:18.60272558 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLC40A1 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:2.82E-15; Fold-change:0.46271086; Z-score:5.947384832 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Oligodendroglioma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypermethylation of SLC40A1 in oligodendroglioma than that in healthy individual | ||||
Studied Phenotype |
Oligodendroglioma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:6.32E-41; Fold-change:0.55188235; Z-score:3.644433598 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.